The effects stop a few months after you stop taking the medication. Targeted breast cancer therapy. These medications, including palbociclib (Ibrance), pertuzumab (Perjeta), and ribociclib (Kisqali), may cause hair loss in some people. You’ll notice it right away, and your hair won’t ...
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesisAdherenceAdjuvant hormone therapyAromatase inhibitorBreast cancerEndocrine therapyPersistence...
All these side effects were similarly detected in mice treated with vincristine. After the first days of treatment, all the animals started to grow again.Our ... MC Manara,L Landuzzi,P Nanni,... - 《Clinical Cancer Research An Official Journal of the American Association for Cancer Research...
Medications used to lower breast cancer risk include selective estrogen receptor modulators (SERMs), such as tamoxifen and raloxifene, and aromatase inhibitors, such as anastrozole and exemestane. SERMs block the effects of estrogen in breast tissue, which decreases breast cancer risk. However, they ...
In some cases, the drugs used to manage side effects cause other symptoms. And they are often costly. (More information can be found in our XRAY review on the cost of medication for the treatment of side effects). Many breast cancer survivors benefit from non-medicinal approaches, such as ...
Adverse effects of radiation therapy (StatPearls Publishing, 2020). Google Scholar Peddie, N. et al. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis. Breast 58, 147–159 (2021...
Patients with a history of HR+ breast cancer who had received a recommendation to take ET were eligible to participate in the anonymous, online survey.ResultsRespondents included 2353 women and 54 men. Aromatase inhibitors were the most commonly used medication. Side effects were reported by 91.2%...
The selection of interview partners continued until theoretical data saturation was achieved.As main arguments against participation emotional overload and too many medication side-effects were stated. Improvement of health-related values, long-term protection and comprehensive follow-up exams were stated ...
- 《Supportive Care in Cancer Official Journal of the Multinational Association of Supportive Care in Cancer》 被引量: 0发表: 2019年 加载更多研究点推荐 Estrogen-Receptor Positive Breast Cancer Everolimus Medication-Related Osteonecrosis nate therapy osteonecrosis bisphosphonates 站内活动 ...
Medication adherenceThe treatment of metastatic breast cancer (mBC) focuses on prolonging patient survival, providing adequate symptom management, and maintaining quality of life (QoL). This includes supportive therapy to prevent or treat potential side effects and handle comorbidities. The combination of...